Elanco Animal Health Incorporated

ELAN Healthcare Drug Manufacturers Specialty & Generic

Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.

Revenue
+10.2%
EPS
+450.0%
Free cash flow
+35.6%
Total debt
−6.91%

Quarter to June 2026, against a year earlier

23.74 1.57 −6.20%
Market cap
$11.8B
P/E
0.0×
Fwd P/E
161×
Dividend yield
—
F-score
5/9
Altman Z
1.28
Beneish M
−2.68
Dividend safety
n/a

Elanco Animal Health Incorporated (ELAN) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Elanco Animal Health Incorporated (ELAN) trades at a EV/FCF of 42.7×. Over the past ten years it has ranged from −1,607× (November 2021) to 1,038× (December 2019); the current reading is higher than 61% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 56.1× 112.29%
FY2024 26.4× (75.51%)
FY2023 108× 151.08%
FY2022 43.0× (36.97%)
FY2021 68.2× —
FY2020 −68.4× —
FY2019 −218× —
FY2018 32.3× (24.76%)
FY2017 42.9× 0.00%
FY2016 42.9× 0.00%

Quarterly newest first

Period EV/FCF Change
Jun 2026 43.9× (16.83%)
Mar 2026 52.8× (5.91%)
Dec 2025 56.1× 43.59%
Sep 2025 39.1× 23.13%
31 more quarters

Against its own ten years

Low −1,607× High 1,038×
Ten-year median 37.1×
Current reading's percentile 46

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on ELAN